Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
125
datasets available to search
ShareScore release 0.9.0
Dataset results
125 results for “Relapsing-remitting multiple sclerosis”
A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT07189325. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea
ClinicalTrials.gov study NCT01071694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT01039103. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00219908. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
ClinicalTrials.gov study NCT00337779. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
ClinicalTrials.gov study NCT06796504. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00035529. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity
ClinicalTrials.gov study NCT07292480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT05532163. IPD Sharing: YES. Countries: 1. Publications: 0.
Melatonin in Relapsing-Remitting Multiple Sclerosis Patients
ClinicalTrials.gov study NCT01279876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
ClinicalTrials.gov study NCT05423769. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT06083753. IPD Sharing: NO. Countries: 1. Publications: 0.
Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Reg
ClinicalTrials.gov study NCT04468165. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00217295. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT05906992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of BCD-132 in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT03551275. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®
ClinicalTrials.gov study NCT01075880. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT05920018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04711148. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
ClinicalTrials.gov study NCT05811416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.